Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors (CNTO95/Avastin)

This study has been completed.
Sponsor:
Collaborators:
Centocor, Inc.
Genentech, Inc.
Information provided by (Responsible Party):
Herbert Hurwitz, MD, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00888043
First received: April 23, 2009
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)